Kimia Biosciences [KIMIABL] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Kimia Biosciences

BSE
Loading...

Gujarat Themis

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kimia Biosciences wins in 5 metrics, Gujarat Themis wins in 7 metrics, with 0 ties. Gujarat Themis appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricKimia BiosciencesGujarat ThemisBetter
P/E Ratio (TTM)N/A103.15N/A
Price-to-Book Ratio16.7918.55Kimia Biosciences
Debt-to-Equity Ratio394.9212.27Gujarat Themis
PEG RatioN/A-3.26N/A
EV/EBITDA10.9471.94Kimia Biosciences
Profit Margin (TTM)7.31%30.17%Gujarat Themis
Operating Margin (TTM)6.75%33.14%Gujarat Themis
EBITDA Margin (TTM)6.75%33.14%Gujarat Themis
Return on EquityN/A19.64%N/A
Return on Assets (TTM)N/A16.19%N/A
Free Cash Flow (TTM)N/A$-251.22MN/A
Dividend YieldN/A0.17%N/A
1-Year Return-25.25%89.42%Gujarat Themis
Price-to-Sales Ratio (TTM)1.3931.17Kimia Biosciences
Enterprise Value$2.06B$46.35BGujarat Themis
EV/Revenue Ratio1.7231.35Kimia Biosciences
Gross Profit Margin (TTM)N/A77.71%N/A
Revenue per Share (TTM)$26$14Kimia Biosciences
Earnings per Share (Diluted)N/A$4.10N/A
Beta (Stock Volatility)0.97-0.37Gujarat Themis
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Kimia Biosciences vs Gujarat Themis Stock Performance Analysis

Loading Price Chart...

Kimia Biosciences
Gujarat Themis
Kimia Biosciences Stock Overview | Gujarat Themis Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kimia Biosciences1.05%3.83%2.98%-45.69%-5.32%-16.69%
Gujarat Themis-3.28%5.04%8.07%20.17%66.93%70.32%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kimia Biosciences-25.25%-17.67%18.67%86.90%86.90%86.90%
Gujarat Themis89.42%89.42%89.42%89.42%89.42%89.42%

News Based Sentiment: Kimia Biosciences vs Gujarat Themis

Kimia Biosciences

News based Sentiment: NEGATIVE

Kimia Biosciences experienced a significant decline in stock price and financial performance during the month of October 2025. The substantial drops in net sales and profit, combined with a high debt-to-equity ratio, create a concerning picture for investors. The closure of the trading window and AGM proceedings are standard corporate governance but don't offset the negative financial trends.

View Kimia Biosciences News Sentiment Analysis

Gujarat Themis

News based Sentiment: MIXED

October 2025 was a mixed month for Gujarat Themis Biosyn Ltd., with declining financial results countered by positive stock movement and investor sentiment. While the revenue and profit decreases are concerning, the market's reaction and analyst targets suggest potential for recovery, making it a cautiously optimistic outlook.

View Gujarat Themis News Sentiment Analysis

Performance & Financial Health Analysis: Kimia Biosciences vs Gujarat Themis

MetricKIMIABLGUJTHEM
Market Information
Market Cap i₹1.75B₹46.19B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,546353,996
90 Day Avg. Volume i12,368202,276
Last Close₹37.38₹414.65
52 Week Range₹34.25 - ₹86.85₹208.00 - ₹434.25
% from 52W High-56.96%-4.51%
All-Time High₹86.85 (Jul 02, 2025)₹434.25 (Oct 06, 2025)
% from All-Time High-56.96%-4.51%
Growth Metrics
Quarterly Revenue Growth0.05%-0.08%
Quarterly Earnings Growth-0.58%-0.32%
Financial Health
Profit Margin (TTM) i0.07%0.30%
Operating Margin (TTM) i0.07%0.33%
Return on Equity (TTM) iN/A0.20%
Debt to Equity (MRQ) i394.9212.27
Cash & Liquidity
Book Value per Share (MRQ)₹2.11₹22.80
Cash per Share (MRQ)₹0.04₹1.15
Operating Cash Flow (TTM) i₹0₹970.68M
Levered Free Cash Flow (TTM) i₹0₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: Kimia Biosciences vs Gujarat Themis

MetricKIMIABLGUJTHEM
Price Ratios
P/E Ratio (TTM) iN/A103.15
Forward P/E iN/AN/A
PEG Ratio iN/A-3.26
Price to Sales (TTM) i1.3931.17
Price to Book (MRQ) i16.7918.55
Market Capitalization
Market Capitalization i₹1.75B₹46.19B
Enterprise Value i₹2.06B₹46.35B
Enterprise Value Metrics
Enterprise to Revenue i1.7231.35
Enterprise to EBITDA i10.9471.94
Risk & Other Metrics
Beta i0.97-0.37
Book Value per Share (MRQ) i₹2.11₹22.80

Financial Statements Comparison: Kimia Biosciences vs Gujarat Themis

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)KIMIABLGUJTHEM
Revenue/Sales iN/A₹358.73M
Cost of Goods Sold iN/A₹79.97M
Gross Profit iN/A₹278.76M
Research & Development iN/AN/A
Operating Income (EBIT) iN/A₹118.87M
EBITDA iN/A₹141.96M
Pre-Tax Income iN/A₹121.20M
Income Tax iN/A₹30.58M
Net Income (Profit) iN/A₹90.62M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)KIMIABLGUJTHEM
Cash & Equivalents iN/A₹116.94M
Total Current Assets iN/A₹519.73M
Total Current Liabilities iN/A₹205.60M
Long-Term Debt iN/A₹296.36M
Total Shareholders Equity iN/A₹2.48B
Retained Earnings iN/A₹2.37B
Property, Plant & Equipment iN/A₹411.30M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)KIMIABLGUJTHEM
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKIMIABLGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i5,546353,996
Average Daily Volume (90 Day) i12,368202,276
Shares Outstanding i47.31M108.97M
Float Shares i3.80M30.70M
% Held by Insiders i0.92%0.71%
% Held by Institutions i0.00%0.01%

Dividend Analysis & Yield Comparison: Kimia Biosciences vs Gujarat Themis

MetricKIMIABLGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025